Invention Grant
- Patent Title: Treatment of cancer with specific RXR agonists
-
Application No.: US14994025Application Date: 2016-01-12
-
Publication No.: US09655872B2Publication Date: 2017-05-23
- Inventor: Roshantha A. Chandraratna
- Applicant: IO Therapeutics, Inc.
- Applicant Address: US CA Laguna Hills
- Assignee: IO Therapeutics, Inc.
- Current Assignee: IO Therapeutics, Inc.
- Current Assignee Address: US CA Laguna Hills
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Michelle Glasky Bergman
- Main IPC: A61K31/192
- IPC: A61K31/192 ; A61K45/06 ; A61K31/282 ; A61K31/337 ; C12Q1/68
Abstract:
A method of treating cancer is disclosed comprising administering to a patient in need of such treatment a RXR agonist at a level below the RAR activating threshold and at or above the RXR effective dose.
Public/Granted literature
- US20160120826A1 TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS Public/Granted day:2016-05-05
Information query
IPC分类:
